首页|期刊导航|眼科新进展|甜菊糖苷-白杨素滴眼液通过调控TLR4/MyD88/NF-κB信号通路改善糖尿病干眼小鼠眼表炎症的机制研究

甜菊糖苷-白杨素滴眼液通过调控TLR4/MyD88/NF-κB信号通路改善糖尿病干眼小鼠眼表炎症的机制研究OA

Mechanism of Stevioside-Chrysin ophthalmic solution improving ocular sur-face inflammation in diabetic dry eye mice by regulating the TLR4/MyD88/NF-κB signaling pathway

中文摘要英文摘要

目的 探讨甜菊糖苷(Ste)-白杨素(Chr)(Ste-Chr)滴眼液通过调控TLR4/MyD88/NF-κB信号通路改善糖尿病干眼(DDE)小鼠眼表炎症的作用机制.方法 取8周龄SPF级健康雄性C57BL/6J小鼠40只,适应性饲养1周后,以55 mg·kg-1剂量腹腔注射链脲佐菌素溶液,连续注射5 d,建立DDE模型.最终,35只小鼠DDE造模成功,3只诱导失败,2只死亡.从35只造模成功的小鼠中随机选取32只,采用随机数字表法分为4组(每组8只):模型组、环孢素(CsA)组、Chr组和Ste-Chr组,另设8只健康雄性C57BL/6J小鼠作为对照组.DDE模型组与对照组均不给予任何药物干预;CsA组给予小鼠0.5 g·L-1 CsA滴眼液;Chr组给予5 g·L-1 Chr混悬液;Ste-Chr组给予Ste-Chr滴眼液.各组治疗药物均使用微量移液器精准吸取,双眼给药,每眼5 μL,滴于小鼠下结膜穹窿部,每天3次(给药时间为8:00、14:00、20:00),连续干预2周.于造模前、造模结束后及干预结束后分别检测各组小鼠血糖,并评估角膜荧光素染色(FL)评分、泪膜破裂时间(BUT)及泪液分泌量等干眼相关指标;采用HE染色观察小鼠角膜组织形态结构;运用qRT-PCR技术检测角膜组织中TLR4、NF-κB、肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6及IL-1β的mRNA表达水平;通过Western blot法分析角膜组织中TLR4、MyD88与NF-κB蛋白的表达变化.结果 造模结束后及药物干预结束时,与对照组相比,模型组与各药物干预组小鼠的血糖均显著升高(均为P<0.01).干预结束后,与模型组相比,CsA组与Ste-Chr组小鼠FL评分均显著降低,BUT及泪液分泌量均明显升高(均为P<0.01);与CsA组相比,Chr组小鼠FL评分升高,BUT及泪液分泌量均降低(均为P<0.05),而Ste-Chr组FL评分进一步降低,BUT及泪液分泌量均升高(均为P<0.05).干预结束后,模型组与Chr组小鼠角膜出现混浊、上皮增厚及基质排列紊乱;而CsA组与Ste-Chr组小鼠角膜透明度良好,上皮与基质结构规整致密.干预结束后,与对照组相比,模型组与各药物干预组小鼠角膜组织中TLR4、NF-κB、TNF-α、IL-6及IL-1β mR-NA表达均显著升高(均为P<0.01).与模型组相比,CsA组与Ste-Chr组小鼠角膜组织中上述炎症因子表达均明显降低(均为P<0.01).与CsA组相比,Chr组小鼠角膜组织中各炎症因子表达均升高(均为P<0.05),而Ste-Chr组则进一步降低(均为P<0.05).干预结束后,与对照组相比,模型组与各药物干预组小鼠角膜组织中TLR4、MyD88与NF-κB蛋白表达均显著升高(均为P<0.01).与模型组相比,CsA组与Ste-Chr组小鼠角膜组织中上述蛋白表达均明显降低(均为P<0.01).与CsA组相比,Chr组小鼠角膜组织中各蛋白表达均升高(均为P<0.05),而Ste-Chr组则进一步降低(均为P<0.05).结论 Ste-Chr滴眼液可通过抑制TLR4/MyD88/NF-κB信号通路,下调角膜组织中TLR4、MyD88与NF-κB在基因与蛋白水平的表达,并降低IL-1β、TNF-α及IL-6等促炎因子水平,从而有效缓解DDE模型小鼠的眼表炎症反应.

Objective To investigate the mechanism of Stevioside(Ste)-Chrysin(Chr)(Ste-Chr)ophthalmic solu-tion improving ocular surface inflammation in diabetic dry eye(DDE)mice by regulating the TLR4/MyD88/NF-κB signaling pathway.Methods Forty 8-week-old SPF-grade healthy male C57BL/6J mice were selected.After one week of adaptive feeding,mice were intraperitoneally injected with streptozotocin solution at a dose of 55 mg·kg-1 for 5 consecutive days to establish DDE models.Eventually,35 mice were successfully induced into the DDE model,3 failed to be induced,and 2 died.Thirty-two mice were randomly selected from the 35 successfully modeled mice and divided into 4 groups(8 mice in each group)using a random number table method:model group,cyclosporine(CsA)group,Chr group,and Ste-Chr group.Additionally,8 healthy male C57BL/6J mice were set as a control group.Neither the DDE model group nor the control group was given any drug intervention;mice in the CsA group were administered 0.5 g·L-1 CsA eye drops;mice in the Chr group were administered 5 g·L-1 Chr suspension;and mice in the Ste-Chr group were administered Ste-Chr ophthalmic solution.The therapeutic drugs in each group were precisely aspirated using a micropipette,administered to both eyes,with 5 μL per eye,and dripped into the inferior conjunctival fornix,three times a day(at 8:00,14:00,and 20:00)for 2 consecutive weeks.Before modeling,after modeling,and after intervention,blood glucose levels of mice in each group were measured,and dry eye-related indicators such as corneal fluorescein staining(FL)score,tear film break-up time(BUT),and tear secretion volume were evaluated.Hematoxylin-eosin staining was performed to observe the morphological structure of corneal tissue in mice.Quantitative real-time polymerase chain reaction was employed to detect the mRNA expression levels of TLR4,NF-κB,tumor necrosis factor(TNF)-α,interleukin(IL)-6,and IL-1β in corneal tissue.Western blot was used to analyze the changes in protein expressions of TLR4,MyD88,and NF-κB in corneal tissue.Results After modeling and drug interven-tion,compared with the control group,blood glucose levels of mice in the model group and each drug intervention group increased significantly(all P<0.01).After intervention,compared with the model group,the FL scores of mice in the CsA group and Ste-Chr group significantly decreased,while the BUT and tear secretion volume significantly increased(all P<0.01).Compared with the CsA group,the FL scores of mice in the Chr group increased,and the BUT and tear secretion volume decreased(all P<0.05),whereas the FL scores of mice in the Ste-Chr group further decreased,and the BUT and tear secretion volume further increased(all P<0.05).After intervention,the corneas of mice in the model group and Chr group showed opacity,epithelial thickening,and disordered stromal arrangement;while the corneas of mice in the CsA group and Ste-Chr group exhibited good transparency,and the epithelial and stromal structures were regular and dense.After intervention,compared with the control group,the mRNA expression levels of TLR4,NF-κB,TNF-α,IL-6,and IL-1β in the corneal tissue of mice in the model group and each drug intervention group significantly increased(all P<0.01).Compared with the model group,the expression of the above inflammatory factors in the corneal tissue of mice in the CsA group and Ste-Chr group significantly decreased(all P<0.01).Compared with the CsA group,the expression of various in-flammatory factors in the corneal tissue of mice in the Chr group increased(all P<0.05),while those in the Ste-Chr group further decreased(all P<0.05).After intervention,compared with the control group,the expression of TLR4,MyD88,and NF-κB proteins in the corneal tissue of mice in the model group and each drug intervention group significantly increased(all P<0.01).Compared with the model group,the expression of the above proteins in the corneal tissue of mice in the CsA group and Ste-Chr group significantly decreased(all P<0.01).Compared with the CsA group,the expression of each protein in the corneal tissue of mice in the Chr group increased(all P<0.05),while those in the Ste-Chr group further decreased(all P<0.05).Conclusion Ste-Chr ophthalmic solution can effectively alleviate ocular surface inflammatory response in DDE model mice by inhibiting the TLR4/MyD88/NF-κB signaling pathway,down-regulating the gene and protein expression of TLR4,MyD88,and NF-κB in corneal tissue,and reducing the levels of pro-inflammatory factors such as IL-1β,TNF-α,and IL-6.

李晓丹;孙斌;李丁丁;陈涛;辛萌

264100 山东省烟台市,滨州医学院烟台附属医院264100 山东省烟台市,滨州医学院烟台附属医院430000 湖北省武汉市,武汉大学中南医院264100 山东省烟台市,滨州医学院烟台附属医院264100 山东省烟台市,滨州医学院烟台附属医院

医药卫生

甜菊糖苷白杨素糖尿病干眼炎症TLR4/MyD88/NF-κB信号通路

steviosidechrysindiabetic dry eyeinflammationTLR4/MyD88/NF-κB signaling pathway

《眼科新进展》 2026 (3)

197-202,6

山东省医药卫生科技项目(编号:202307021104)

10.13389/j.cnki.rao.2026.0035

评论